Glycobreez-I HMPC DPI Capsule 10's

Glycobreez-I HMPC DPI Capsule 10's is indicated for long-term, maintenance treatment of Chronic Obstructive Pulmonary Disease (COPD). COPD is a group of lung diseases with emphysema (shortness of breath) and chronic bronchitis (inflammation of the bronchial tube lining).

Glycobreez-I HMPC DPI Capsule 10's is a combination of two medicines, namely: Indacaterol and Glycopyrronium. Indacaterol relaxes and widens the openings in the airways, making it easier to breathe. Glycopyrronium decreases the secretions in the airways. Together, Glycobreez-I HMPC DPI Capsule 10's provides relief from COPD.

In some cases, you may experience certain common side effects such as upper respiratory tract infection, inflammation of the sinuses, runny/stuffy nose, headache, dizziness, and stomach upset. Most of these side effects do not require medical attention and will resolve gradually over time. However, you are advised to talk to your doctor if you experience these side effects persistently.

Do not stop taking Glycobreez-I HMPC DPI Capsule 10's on your own, as it might cause worsening of symptoms. Consult your doctor before taking Glycobreez-I HMPC DPI Capsule 10's if you are pregnant or breastfeeding. Glycobreez-I HMPC DPI Capsule 10's may cause dizziness, so drive with caution. Avoid consuming alcohol, as it might cause increased dizziness.

Glycobreez-I HMPC DPI Capsule 10's is not recommended for children below 18 years, as the safety and effectiveness have not been established. Keep your doctor informed about your health condition and the medicines you are taking to avoid any interactions.

Glycobreez-I HMPC DPI Capsule 10's is used to manage chronic respiratory conditions. The detailed uses of Glycobreez-I HMPC DPI Capsule 10's include:

• Treatment of Chronic Obstructive Pulmonary Disease (COPD): Glycobreez-I HMPC DPI Capsule 10's helps relieve symptoms such as breathlessness, coughing, and wheezing associated with COPD by relaxing airway muscles and reducing secretions.
• Maintenance therapy for airflow obstruction: Glycobreez-I HMPC DPI Capsule 10's is used as a long-term maintenance treatment to improve lung function and reduce the risk of flare-ups in individuals with COPD.

• Follow your doctor’s instructions on the dosage and timing of this medication to ensure safe and effective use.
• Check the label for directions before using it. Place the capsule in the inhaler device, press both side buttons at the same time until you hear a sound to pierce the capsule. Release side buttons. Place the mouthpiece into your mouth and seal your lips around it. Inhale deeply through the mouthpiece.
• Glycobreez-I HMPC DPI Capsule 10's is for inhalation only. Do not swallow the capsules.
• The capsules must always be stored in the blister, and only removed immediately before use.
• The capsules are for use only with the inhaler provided in the pack.
• Discard inhaler after 30 days of use.

• Provides long-term maintenance treatment for chronic obstructive pulmonary disease (COPD), including chronic bronchitis and emphysema.
• Indacaterol, a long-acting beta-2 agonist (LABA), helps relax and widen the airway muscles, improving airflow and breathing comfort.
• Glycopyrronium works by preventing airway constriction and keeping the air passages open.
• The dual bronchodilator action ensures better and longer-lasting control of COPD symptoms for up to 24 hours.
• Helps reduce breathlessness, wheezing, chest tightness, and coughing associated with COPD.
• Improves lung capacity, oxygen intake, and overall respiratory function.
• Ensures accurate dosing and effective delivery of medicine directly into the lungs.

• Do not take Glycobreez-I HMPC DPI Capsule 10's if you are allergic to any of its components.
• Inform your doctor if you have asthma, heart problems, seizures/epilepsy, thyroid gland problems, diabetes, narrow-angle glaucoma, kidney problems, severe liver problems, if you have any difficulty in passing urine or if you are taking any medicines for lung diseases.
• Consult your doctor if you are pregnant or breastfeeding.
• Glycobreez-I HMPC DPI Capsule 10's may cause dizziness, so drive with caution.
• Avoid consuming alcohol, as it might cause increased dizziness.
• Glycobreez-I HMPC DPI Capsule 10's is not recommended for children below 18 years, as safety and effectiveness have not been established.